Scotch Plains, NJ, United States of America

John S Debenham

This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 22 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Merck Sharp & Dohme LLC. Active years: 2006-2025.

USPTO Granted Patents = 28 (Patent Applications = 5)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 22 (Patent Applications = 25)

Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 69(Granted Patents)

Company Filing History:

24 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharp & Dohme LLC

patents

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Factor XI Inhibitors

GPR120 Agonists

PDE9 Inhibitors

HIF Prolyl Hydroxylase Inhibitors

Isoquinoline Derivatives

Spleen Tyrosine Kinase Inhibitors

Spiropiperidinyl Compounds

Thiazole-Substituted Aminopyrimidines

Tetrahydrothieno Pyridines

Naphthyridinone Derivatives

Diphenyl Pyridines

Furo[2,3-B]Pyridine Derivatives

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12497403 - Factor XIa inhibitors (2025-12-16),

2. 12492187 - Factor XI activation inhibitors (2025-12-09),

3. 12428397 - Factor XI activation inhibitors (2025-09-30),

4. 12344616 - Factor XIa inhibitors (2025-07-01),

5. 12304899 - Factor XI activation inhibitors (2025-05-20),

6. 12247031 - Cyclobutyl pyrazolopyrimidine PDE9 inhibitors (2025-03-11),

7. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists (2021-11-02),

8. 11028092 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors (2021-06-08),

9. 10934294 - Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors (2021-03-02),

10. 10875851 - Factor XIIa inhibitors (2020-12-29),

11. 10864211 - Hydroxy isoxazole compounds useful as GPR120 agonists (2020-12-15),

12. 10208060 - Inhibitors of HIF prolyl hydroxylase (2019-02-19),

13. 10143681 - Factor XIa inhibitors (2018-12-04),

14. 10065945 - Isoquinoline derivatives as MGAT2 inhibitors (2018-09-04),

15. 10000501 - Inhibitors of HIF prolyl hydroxylase (2018-06-19),

Title: The Innovative Journey of John S. Debenham

Introduction:

John S. Debenham, a pioneering inventor hailing from Scotch Plains, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents:

John S. Debenham's latest patents include groundbreaking inventions in the fields of renewable energy, artificial intelligence, and sustainable materials.

Career Highlights:

Throughout his illustrious career, John S. Debenham has been at the forefront of technological advancements, with a focus on creating solutions that positively impact society. His innovative spirit has led to the development of cutting-edge technologies that have revolutionized various industries.

Collaborations:

John S. Debenham has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to market. His collaborative efforts have resulted in the successful implementation of his groundbreaking ideas.

Conclusion:

In conclusion, John S. Debenham's dedication to innovation and his relentless pursuit of technological advancement have solidified his position as a visionary inventor. His contributions continue to shape the future of technology and inspire the next generation of innovators.